Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  World Journal of Hepatology

• Publication date

  2016-04-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.4254/wjh.v8.i12.533PMID 27134701PMCID PMC4840159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of Colorectal Cancer After Solid Organ Transplantation in the United States

  2016cited by this paper
• TUMORES MALIGNOS DE NOVO EN EL TRASPLANTE HEPÁTICO EXPERIENCIA DE UN CENTRO EN LA ARGENTINA

  2015cited by this paper
• [De novo malignant tumors following liver transplantation. A single-center experience in Argentina].

  2015cited by this paper
• De novo malignancy after liver transplant.

  2015cited by this paper
• Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis

  2014cited by this paper
• Skin Cancers After Liver Transplantation: Retrospective Single-Center Study on 371 Recipients

  2014cited by this paper
• New Advances in Protection Against Solar Ultraviolet Radiation in Textiles for Summer Clothing

  2014cited by this paper
• De novo Cancers Following Liver Transplantation: A Single Center Experience in China

  2014cited by this paper
• De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008.

  2013cited by this paper
• Comparison of De Novo Cancer Incidence in Australian Liver, Heart and Lung Transplant Recipients

  2013cited by this paper
• Early and Late De Novo Tumors after Liver Transplantation in Adults: The Late Onset of Bladder Tumors in Men

  2013cited by this paper
• Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients

  2013cited by this paper
• De novo Cancer‐Related Death in Australian Liver and Cardiothoracic Transplant Recipients

  2013cited by this paper
• De novo malignancies after organ transplantation: focus on viral infections.

  2013cited by this paper
• Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.

  2013cited by this paper
• Meta‐analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma

  2013cited by this paper
• De novo malignancy post–liver transplantation: a single center, population controlled study

  2013cited by this paper
• Lung cancer screening with low-radiation dose computed tomography after liver transplantation.

  2013cited by this paper
• Sirolimus and secondary skin-cancer prevention in kidney transplantation.

  2012cited by this paper
• Plasmablastic Posttransplant Lymphoma: Cytogenetic Aberrations and Lack of Epstein-Barr Virus Association Linked With Poor Outcome in the Prospective German Posttransplant Lymphoproliferative Disorder Registry

  2012cited by this paper
• De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry.

  2012cited by this paper
• Switching to sirolimus monotherapy for de novo tumors after liver transplantation. A preliminary experience.

  2011cited by this paper
• Epstein-Barr Virus–Associated B-cell Lymphomas: Pathogenesis and Clinical Outcomes

  2011cited by this paper
• Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

  2011cited by this paper
• Spectrum of cancer risk among US solid organ transplant recipients.

  2011cited by this paper
• Organ transplantation and skin cancer: basic problems and new perspectives

  2010cited by this paper
• Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.

  2010cited by this paper
• Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review

  2010cited by this paper
• Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit

  2010cited by this paper
• Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma

  2010cited by this paper
• Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: An association with C2 monitoring and recipient age

  2010cited by this paper
• Diagnosis of post‐transplant lymphoproliferative disorder in solid organ transplant recipients – BCSH and BTS Guidelines

  2010cited by this paper
• Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.

  2010cited by this paper
• Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

  2010cited by this paper
• Indications and management of everolimus after liver transplantation.

  2009cited by this paper
• Long-term probability of and mortality from de novo malignancy after liver transplantation.

  2009cited by this paper
• Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.

  2009cited by this paper
• De Novo Cancers Arising in Organ Transplant Recipients are Associated With Adverse Outcomes Compared With the General Population

  2009cited by this paper
• Cancer and viral infections in immunocompromised individuals

  2009cited by this paper
• Predictors of outcome in post-transplant lymphoproliferative disorder: an evaluation of tumor infiltrating lymphocytes in the context of clinical factors

  2009cited by this paper
• Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation

  2009cited by this paper
• Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report

  2009cited by this paper
• Alcohol abuse and de novo tumors in liver transplantation.

  2009cited by this paper
• Post‐transplant lymphoproliferative disorder after pediatric liver transplantation: Characteristics and outcome

  2009cited by this paper
• Prevention of non‐melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case–control study

  2009cited by this paper
• Extensive Surveillance Promotes Early Diagnosis and Improved Survival of De Novo Malignancies in Liver Transplant Recipients

  2009cited by this paper
• Malignancy after liver transplantation: cumulative risk for development.

  2009cited by this paper
• Smoking‐related morbidity and mortality following liver transplantation

  2008cited by this paper
• Liver transplantation and subsequent risk of cancer: Findings from a Canadian cohort study

  2008cited by this paper
• mTOR, Cancer and Transplantation

  2008cited by this paper
• Risk of malignant neoplasms after liver transplantation: A population‐based study

  2008cited by this paper
• Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors: Reassessment of Risk Factors for Tumor Recurrence

  2008cited by this paper
• More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine

  2008cited by this paper
• Molecular mechanisms of alcohol-mediated carcinogenesis

  2007cited by this paper
• A 30-Year Analysis of Colorectal Adenocarcinoma in Transplant Recipients and Proposal for Altered Screening

  2007cited by this paper
• CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.

  2007cited by this paper
• Identifying High Risk Groups and Quantifying Absolute Risk of Cancer After Kidney Transplantation: A Cohort Study of 15 183 Recipients

  2007cited by this paper
• Clinically Relevant Immunosuppressants Influence UVB‐Induced Tumor Size Through Effects on Inflammation and Angiogenesis

  2007cited by this paper
• Calcineurin inhibitors and rapamycin: cancer protection or promotion?

  2007cited by this paper
• Negative Impact of De Novo Malignancies Rather than Alcohol Relapse on Survival After Liver Transplantation for Alcoholic Cirrhosis: A Retrospective Analysis of 305 Patients in a Single Center

  2007cited by this paper
• Post‐Transplant Lymphoproliferative Disorders Following Liver Transplantation: Incidence, Risk Factors and Survival

  2006cited by this paper
• Post-transplant lymphoproliferative disorders.

  2006cited by this paper
• High prevalence of vitamin D inadequacy and implications for health.

  2006cited by this paper
• De novo malignancies following liver transplantation: a case–control study with long‐term follow‐up

  2006cited by this paper
• Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies

  2005cited by this paper
• Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage

  2005cited by this paper
• Prospective Registry‐Based Observational Cohort Study of the Long‐Term Risk of Malignancies in Renal Transplant Patients Treated with Mycophenolate Mofetil

  2005cited by this paper
• De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population.

  2005cited by this paper
• Incidence of Cancers Following Orthotopic Liver Transplantation in a Single Center: Comparison with National Cancer Incidence Rates for England and Wales

  2005cited by this paper
• De Novo neoplasia after liver transplantation: An analysis of risk factors and influence on survival

  2005cited by this paper
• Nonmelanoma skin cancer after liver transplantation. Study of risk factors

  2005cited by this paper
• Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.

  2005cited by this paper
• Incidence and risk factors for cancer after liver transplantation.

  2005cited by this paper
• The immunobiology of cancer immunosurveillance and immunoediting.

  2004cited by this paper
• Immunosuppressants and Skin Cancer in Transplant Patients: Focus on Rapamycin

  2004cited by this paper
• De Novo Internal Neoplasms after Liver Transplantation: Increased Risk and Aggressive Behavior in Recent Years?

  2004cited by this paper
• PRO- AND ANTI-CANCER EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED IN ORGAN TRANSPLANTATION

  2004cited by this paper
• Cancer risk following organ transplantation: a nationwide cohort study in Sweden

  2003cited by this paper
• Upper aerodigestive tract and lung tumors after liver transplantation.

  2003cited by this paper
• Skin cancers after organ transplantation.

  2003cited by this paper
• Liver Transplant Recipients Older Than 60 Years Have Lower Survival and Higher Incidence of Malignancy

  2003cited by this paper
• Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis

  2003cited by this paper
• Human herpesvirus 8 epidemiology: what we do and do not know

  2003cited by this paper
• A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

  2003cited by this paper
• De novo tumors after liver transplantation: a single-center experience.

  2003cited by this paper
• Human herpesvirus 8 epidemiology: what we do and do not know.

  2003cited by this paper
• Risk factors associated with the development of skin cancer after liver transplantation

  2002cited by this paper
• Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation

  2002cited by this paper
• Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients

  2002cited by this paper
• De novo tumors after orthotopic liver transplantation.

  2002cited by this paper
• De novo tumors after liver transplantation: A single‐institution experience

  2002cited by this paper
• Increased cancer risk after liver transplantation: a population-based study.

  2001cited by this paper
• Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

  2001cited by this paper
• Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.

  2001cited by this paper
• Analysis of causes of death in liver transplant recipients who survived more than 3 years

  2001cited by this paper
• Risk factors for development of de novo neoplasia after liver transplantation

  2001cited by this paper
• Viral infections and cancer: epidemiological aspects.

  2001cited by this paper
• Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.

  2000cited by this paper
• Organization of a specialty clinic to optimize the care of organ transplant recipients at risk for skin cancer.

  2000cited by this paper
• Smoking and drinking cessation and risk of esophageal cancer (Spain)

  2000cited by this paper

• De novo malignancies after liver transplantation: a 30-year multicenter Brazilian cohort.

  2026cites this paper
• Incidence, screening, and management of de novo malignancies in liver transplant patients: A review

  2025cites this paper
• Smoking and liver diseases: an updated review of pathogenesis, progression, and therapeutic implications

  2025cites this paper
• The emerging role of liver transplantation in metastatic colorectal cancer.

  2025cites this paper
• Long-Term Care of the Liver Transplant Recipient.

  2025cites this paper
• Overview of Pediatric Liver Transplantation Surgery

  2024cites this paper
• Complications in Post-Liver Transplant Patients

  2023cites this paper
• Risk of malignant disease in 1-year sepsis survivors, a registry-based nationwide follow-up study

  2023cites this paper
• Clinical Features of de Novo Lung Neuroendocrine Tumor after Liver Transplantation for Hepatocellular Carcinoma

  2022cites this paper
• Psychosocial evaluation for liver transplantation: A brief guide for gastroenterologists

  2021cites this paper
• Сlinical features of malignant tumors against the background of immunosuppressive therapy in heart transplant recipients

  2021cites this paper
• Liver transplantation-associated lung cancer in smokers: results of an early CT detection program

  2021cites this paper
• Особенности течения злокачественных новообразований на фоне иммуносупрессивной терапии у реципиентов сердца

  2021cites this paper
• Psychosocial evaluation for liver transplantation: A brief guide for gastroenterologists.

  2021cites this paper
• Inflammatory Response Mechanisms of the Dentine–Pulp Complex and the Periapical Tissues

  2021cites this paper
• Robotic surgical system completed radical gastrectomy for gastric cancer after liver transplantation: case report and systematic review

  2020cites this paper
• Malignant transformation of oral leukoplakia is associated with macrophage polarization

  2020cites this paper
• Liver Transplantation for Alcoholic Liver Disease: What Is the Risk and Consequence of Relapse?

  2020cites this paper
• Immunosuppressive Treatment With mTOR Inhibitors for Malignancies After Liver Transplantation: Long-Term Survival Retrospective Analysis.

  2020cites this paper
• Liver transplantation for non-resectable colorectal liver metastasis: where we are and where we are going

  2020cites this paper
• Злокачественные новообразования внепеченочной локализации после трансплантации печени: опыт одного трансплантационного центра

  2020cites this paper
• Active Smoking Before Liver Transplantation in Patients with Alcohol Use Disorder: Risk Factors and Outcomes

  2020cites this paper
• Liver transplantation for secondary liver tumors: the difficult balance between survival and recurrence.

  2020cites this paper
• Alcohol and other substance use after liver transplant.

  2020cites this paper
• Long-term Management of the Adult Liver Transplantation Recipients.

  2020influential citation
• Extrahepatic Malignancies and Liver Transplantation: Current Status.

  2020cites this paper
• Preventive Health in the Adult Solid Organ Transplant Recipient

  2020cites this paper
• PD1 expression and correlation with its ligands in oral cancer specimens and peripheral blood.

  2020cites this paper
• Extrahepatic malignant neoplasms after liver transplantation: the experience of a single transplant center

  2020cites this paper
• Primary Care of the Solid Organ Transplant Recipient

  2020cites this paper
• Cancer risk, screening and surveillance in primary sclerosing cholangitis.

  2019cites this paper
• DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report

  2019cites this paper
• Psychopharmacology in transplantation medicine

  2019cites this paper
• Diagnosis and outcome of resected solitary pulmonary nodules after liver transplantation.

  2019cites this paper
• Impact of a Prohibitive Versus Restrictive Tobacco Policy on Liver Transplant Candidate Outcomes

  2019influential citation
• Liver transplantation for colorectal liver metastasis

  2019cites this paper
• De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder.

  2018cites this paper
• Very late onset post-transplant diffuse large B cell lymphoma in a liver transplant recipient with hepatitis B

  2018influential citation
• A retrospective analysis of post‐transplant lymphoproliferative disorder following liver transplantation

  2018cites this paper
• Post-transplant Outcomes of Persons Receiving a Liver Graft for Alcoholic Liver Disease

  2018cites this paper
• Survival following liver transplantation for liver‐only colorectal metastases compared with hepatocellular carcinoma

  2018cites this paper
• The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases

  2018cites this paper
• Immunosuppression following organ transplantation. Part 2: complications and their management.

  2018cites this paper
• Incidence and survival rate of de novo tumors in liver transplants.

  2018cites this paper
• Incidence and Survival Rate of de novo Tumors in Liver Transplants

  2018cites this paper
• Liver transplantation and alcoholic liver disease: History, controversies, and considerations

  2018cites this paper
• Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases

  2018cites this paper
• Alcohol and Liver Transplantation.

  2017cites this paper
• Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo

  2017cites this paper
• Síndrome linfoproliferativo en el trasplante hepático

  2017cites this paper
• Increased Incidence of Post-transplant Lymphoproliferative Disorder in Autoimmune Liver Disease: An Irish National Experience.

  2017cites this paper
• De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.

  2017cites this paper
• Pediatric Liver Transplant: Techniques and Complications.

  2017cites this paper
• Post-transplant lymphoproliferative disease in liver transplant recipients.

  2017cites this paper
• A rare localised nasal CD30+ primary cutaneous T-cell lymphoma following liver transplantation

  2017cites this paper
• Mechanisms and Strategies for Tolerance in Liver Transplantation

  2016cites this paper